2 min read
ASCO Annual Meeting
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...
1 min read
In the complex landscape of marketing application preparation, data analysis stands as a critical cornerstone that can either propel a submission forward or become its greatest challenge. With shifting deadlines, potential delays in data receipt, and the intricate dance of database locks and unblinding, the biostatistical programming portion of submissions presents both challenges and opportunities for strategic management.
The foundation of successful data analysis begins with team structure. Rather than viewing the submission team as separate entities divided by company lines or departmental boundaries, the most successful approaches treat the team as one cohesive unit driving toward a common goal. This is particularly crucial for biostatistics leads, who must balance their technical expertise with managerial skills.
Key planning elements include:
When facing tight submission timelines – an almost universal challenge – the Statistical Analysis Plan (SAP) emerges as a primary timeline driver. It dictates the pooling approach and allows the planning team to work backwards to develop the optimal data conversion and analysis plan. One often-overlooked strategy involves conducting pre-SAP meetings – strategic discussions that bring together not just biostatistics teams, but also medical writing, regulatory, medical, and other key stakeholders.
For integrated analyses, which often combine various Clinical Study Report (CSR) analyses, quality and consistency become paramount. Statistical teams must familiarize themselves with individual CSRs to understand which analyses have been conducted or are planned, ensuring alignment with the integrated analysis.
Critical quality measures include:
Success in data analysis requires a delicate balance of technical expertise, strategic thinking, and effective team management. By implementing these key strategies while maintaining unwavering commitment to quality, teams can navigate the complex data requirements of marketing applications more effectively and efficiently.
Imagine that your teams have been working at warp speed to meet your NDA timeline and you finally complete the submission to the FDA. You should be celebrating! But wait, the FDA responds with a Refusal to File letter. It happens!
2 min read
Apr 23, 2025 Veristat Events
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...
1 min read
Apr 9, 2025 Veristat Events
Veristat is excited to participate in...